Disclosure Panels Details Page
CLL/SLL/Hairy Cell Leukemia Panel - Disclosures as of 04/24/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Jeremy Abramson MMSc,MD | AbbVie, Inc. BeiGene Bristol Myers Squibb Cellectis Genentech, Inc. MEI Pharma Inc. Merck & Co., Inc. Mustang bio Regeneron Pharmactcls |
AbbVie, Inc. ADC Therapeutics AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Genentech, Inc. Gilead Sciences, Inc. Interius Novartis Pharmaceuticals Corporation SeaGen |
None | None | 04/01/2024 |
| Farrukh Awan MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP |
AbbVie, Inc. Adaptive Biotechnologies AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Dava Oncology Genmab Incyte Corporation Loxo Oncology Pharmacyclics |
None | None | 02/10/2024 |
| Syed Bilgrami MD | None | None | None | None | 07/16/2023 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Greg Bociek MSc,MD | None | Innate Pharma Inc. | None | None | 04/04/2024 |
| Danielle Brander MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Catapult DTRM Genentech, Inc. Merck & Co., Inc. neWave Nurix Pharmacyclics TG therapeutics |
AbbVie, Inc. Genentech, Inc. Pharmacyclics |
None | None | 04/08/2024 |
| Jennifer Brown PhD,MD | Acerta Pharma BeiGene Catapult Celgene Corporation Eli Lilly and Company Gilead Sciences, Inc. Grifols iOnctura Janssen Pharmaceutica Products, LP MEI Pharma Inc. SecuraBio TG Therapeutics |
AbbVie, Inc. Acerta Pharma Alloplex BeiGene Bristol Myers Squibb Eli Lilly and Company Galapagos NV Genentech, Inc. Grifols Innocare Pharma Merck & Co., Inc. Pharmacyclics |
None | None | 04/04/2024 |
| Matthew Cortese MD,MPH | Adicet Bio AstraZeneca Pharmaceuticals LP Ipsen Merck & Co., Inc. Synthekine, Inc. |
AbbVie, Inc. ADC Therapeutics AstraZeneca Pharmaceuticals LP Cellectar Biosciences SeaGen Secura Bio Synthekine Targeted Oncology/MJH Events |
Precision Oncology/MJH Events Secura Bio |
None | 11/17/2023 |
| Larry Cripe MD | None | None | None | None | 01/23/2024 |
| Randall Davis MD | Biolegend | None | None | None | 03/20/2024 |
| Zeenat Diwan PhD,MS | None | None | None | None | 12/11/2023 |
| Mary Dwyer MS | None | None | None | None | 02/12/2024 |
| Herbert Eradat MS,MD | AbbVie, Inc. Acerta Pharma ADC Therapeutics Amgen Inc. Astex Pharmaceuticals AstraZeneca Pharmaceuticals LP ATARA BeiGene Celator Pharmaceuticals Celgene Corporation Genentech, Inc. Gilead Sciences, Inc. Incyte Corporation Infinity Pharmaceuticals, Inc Juno Therapeutics, Inc. Kite Pharma MorphoSys AG Novartis Pharmaceuticals Corporation Regeneron Pharmaceuticals, Inc. Roche Laboratories, Inc. |
AbbVie, Inc. ADC Therapeutics AstraZeneca Pharmaceuticals LP BeiGene Genentech, Inc. Incyte Corporation MorphoSys AG |
None | None | 07/24/2023 |
| Bita Fakhri MD | Bristol Myers Squibb Eli Lilly and Company Genentech, Inc. |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Eli Lilly and Company Genentech, Inc. Pharmacyclics |
Eli Lilly and Company | None | 05/10/2023 |
| Lindsey Fitzgerald MD | None | None | None | None | 03/24/2024 |
| Christopher Fletcher MD | None | None | None | None | 02/26/2024 |
| Sameh Gaballa MD | AstraZeneca Pharmaceuticals LP BeiGene Ipsen Kite Pharma |
BeiGene Genentech, Inc. Genmab Kite Pharma Regeneron Pharmactcls |
ADC Therapeutics Eli Lilly and Company |
None | 04/18/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Muhammad Saad Hamid MD | None | None | None | None | 03/08/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Laura Hanisch PsyD | None | None | None | None | 12/12/2023 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Brian Hill PhD,MD | None | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Epizyme Genentech, Inc. Incyte Corporation Kite Pharma Merck & Co., Inc. MorphoSys AG Novartis Pharmaceuticals Corporation Pharmacyclics SeaGen |
None | None | 04/19/2024 |
| Madeline Joyce OCN,RN,BSN | None | None | None | None | 03/28/2024 |
| Paul Kaesberg MD | None | None | BeiGene Incyte Corporation Janssen Pharmaceutica Products, LP |
None | 03/23/2023 |
| Brad Kahl MD | BeiGene Bristol Myers Squibb Roche Laboratories, Inc. |
AbbVie, Inc. ADCT AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Eli Lilly and Company Genentech, Inc. Janssen Pharmaceutica Products, LP Kite Pharma Merck & Co., Inc. Novartis Pharmaceuticals Corporation SeaGen |
None | None | 01/04/2024 |
| Manali Kamdar MD | Celgene Corporation Genentech, Inc. Novartis Pharmaceuticals Corporation |
None | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb SeaGen |
None | 01/03/2024 |
| Ann Karosas RPh,BCOP | None | None | None | None | 02/26/2024 |
| Thomas Kipps PhD,MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP Janssen Pharmaceutica Products, LP Merck & Co., Inc. Pharmacyclics |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP Dava Oncology Genentech, Inc. Janssen Pharmaceutica Products, LP Pharmacyclics |
None | None | 01/23/2024 |
| Shuo Ma PhD,MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Eli Lilly and Company Juno Therapeutics, Inc. |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Janssen Pharmaceutica Products, LP |
AstraZeneca Pharmaceuticals LP BeiGene Eli Lilly and Company |
None | 03/18/2024 |
| Claudio Mosse PhD,MD | None | None | None | None | 02/08/2024 |
| Shazia Nakhoda MD | AstraZeneca Pharmaceuticals LP Boston Scientific Corporation Bristol Myers Squibb Genentech, Inc. |
ADC Therapeutics BeiGene Bristol Myers Squibb SERB/BTG |
None | None | 01/29/2024 |
| Sameer Parikh MBBS | AstraZeneca Pharmaceuticals LP Genentech, Inc. Merck & Co., Inc. Roche Laboratories, Inc. |
AbbVie, Inc. Ascentage Pharmaceuticals AstraZeneca Pharmaceuticals LP BeiGene Eli Lilly and Company Genentech, Inc. Janssen Pharmaceutica Products, LP Kite Pharma Merck & Co., Inc. Pharmacyclics |
None | None | 04/19/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Peter Riedell MD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Calibr CRISPR Therapeutics Fate Therapeutics Genentech, Inc. Kite Pharma Novartis Pharmaceuticals Corporation Tessa Therapeutics Xencor |
AbbVie, Inc. ADC Therapeutics BeiGene Bristol Myers Squibb Genmab Janssen Pharmaceutica Products, LP Kite Pharma Pharmacyclics |
None | None | 03/02/2024 |
| Andrew Schorr MS | GSK Janssen Pharmaceutica Products, LP Karyopharm Therapeutics MorphoSys AG |
AbbVie, Inc. | GSK | None | 02/09/2024 |
| Stephen Schuster MD | AbbVie, Inc. Acerta Pharma Adaptive Biotech Celgene Corporation Genentech, Inc. Genmab Juno Therapeutics, Inc. Loxo Oncology Novartis Pharmaceuticals Corporation Portola Pharmaceuticals, Inc. TG Therapeutics Zhejiang DTRM Biopharma |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Caribou Biosciences Genentech, Inc. Genmab Incyte Corporation Kite Pharma Legend Biotech MorphoSys AG Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
None | None | 04/24/2023 |
| Madhav Seshadri MD | Eli Lilly and Company Genentech, Inc. |
BeiGene Kite Pharma |
None | None | 02/25/2024 |
| Tanya Siddiqi MD | BeiGene | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Celgene Corporation Gilead Sciences, Inc. Juno Therapeutics, Inc. |
None | None | 03/24/2024 |
| Hema Sundar PhD | None | None | None | None | 12/11/2023 |
| Meghan Thompson MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Genentech, Inc. Genmab Nurix Therapeutics |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP Beigene Dava Oncology Eli Lilly and Company Janssen Pharmaceutica Products, LP |
None | None | 03/10/2024 |
| Chaitra Ujjani MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP Kite Pharma LOXO Pharmacyclics |
AbbVie, Inc. Allogene ascentage AstraZeneca Pharmaceuticals LP Atara BeiGene Bristol Myers Squibb Genentech, Inc. Janssen Pharmaceutica Products, LP Pharmacyclics |
None | None | 12/26/2023 |
| Riccardo Valdez MD | None | None | None | None | 02/16/2024 |
| Nina Wagner-Johnston MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. Merck & Co., Inc. |
None | None | None | 04/19/2024 |
| William Wierda PhD,MD | AbbVie, Inc. Acerta Pharma AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Cyclacel Genentech, Inc. Gilead Sciences, Inc. GSK Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. Kite Pharma Loxo Oncology, Inc./Lilly MDACC Cancer Center Support Grant Miragen NIH Award No. P30 CAO16672 Nonrelevant Financial Relationship- National Comprehensive Cancer Network- Chair Novartis Pharmaceuticals Corporation Numab Therapeutics Nurix Oncternal Therapeutics Pharmacyclics Xencor |
None | None | None | 04/11/2024 |
| Jennifer Woyach MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Eli Lilly and Company Genentech, Inc. Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. MorphoSys AG Newave Pharmacyclics Schrodinger Ing REG SHS |
Newave | None | None | 04/25/2023 |